ENGLISH PUBLICATIONS
(Surgical Endocrinology & Oncology-related Articles) 1) Takami
H, Yamaguchi K, Abe K, Adachi I, Arai S, Kameya T, Yamachika K, Tashiro
M, Nakagawa Y, and Abe O. A case of Zollinger-Ellison syndrome whose pancreatic
tumor produced multiple hormones and a review of 48 cases reported in
the Japanese literature. Jpn J Clin Oncol. 1978;8(1):75-89.
2) Busch H, Ballal NR, Busch RK, Samal B, Choi YC, Davis FM, Kunkle HM,
Nall K, Parker D, Rao MS, Rothblum LI, Takami H. Hierarchical controls
of nucleolar synthetic functions. Differentiation and Development. New
York, Academic Press, pp 187-209, 1978
3) Takami H, Busch H. Two-dimensional gel electrophoretic comparison
of proteins of nuclear fractions of normal liver and Novikoff hepatoma.
Cancer Res. 1979;39(2):507-518.
4) Takami H, Busch FN, Morris HP, Busch H. Comparison of salt-extractable
nuclear proteins of regenerating liver, fetal liver, and Morris hepatoma
9618A and 3924A. Cancer Res. 1979;39(6):2096-2105.
5) Busch H, Takami H, Davis FM, Busch RK, Wu BC, Spohn WH, Raju KS. Nonhistone
nuclear proteins of cancer cells. In: Fox M (ed), Advances in medical
oncology, research and education, vol.4, Biological basis for cancer diagnosis,
1st ed. Oxford and New York, Pergamon Press, pp 21-26, 1979
6) Takami H, Romsdahl MM, Nishioka K. Polyamines in blood-cells as a
cancer marker. Lancet. 1979;2:912-913.
7) Takami H, Nishioka K. Raised polyamines in erythrocytes from melanoma-bearing
mice and patients with solid tumors. Br J Cancer. 1980;41(5):751-756.
8) Takami H, Abe O. Alterations of cytoplasmic proteins in rat hepatomas
during the administration of chemical carcinogen. Keio J Med. 1980;29(1):9-17.
9) Nishioka K, Takami H, Noyes RD, Babcock GF. CloudmanS-91 melanoma
colony assay in the lungs of mice and profiles of the biochemical tumor
markers tyrosinase and polyamines. In: Seiji M (eds), Pigment cell 1981:
Phenotypic expression in pigment cells. Tokyo, University of Tokyo Press,
pp 617-621, 1981
10) Mimura T, Hamada N, Ban Y, Mori H, Momotani N, Takami H, Nishikawa
Y, Ito K. Anterior pituitary, thyroid, parathyroid and adrenal responses
to subtotal thyroidectomy in patients with Graves' disease. Jpn J Surg.
1982;12(4):235-243.
11) Yamamoto O, Takami H, Motomura Y, Miyata J, Hosoda Y, Mimura T, Ito
K, Abe O. Polyamine levels and ornithine decarboxylase activities in human
thyroid tumors. In: Ui N, Torizuka K (eds), Current problems in thyroid
research. Amsterdam-Oxford-Princeton, Excerpta Medica, pp 533-536, 1983
12) Takami H, Umemoto S, Kodaira S, Ishibiki K, Abe,O. Antitumor effect
of α-difluoromethyl ornithine (DFMO) and ornithine decarboxylase activity
in a human tumor transplanted into nude mice. In: Imahori K, Suzuki F,
Suzuki O & Bachrach U (eds), Polyamines: Basic and clinical aspects.
Proceedings of a satellite symposium of the 3rd international congress
on cell biology. Utrecht, VNU Science Press, pp 285-291, 1985
13)Taketa K, Ichikawa E, Akamatsu K, Ohta Y, Sekiya C, Namiki M, Takami
H, Kaneda H, Higashino K, Taga H, Hirai H. Increased asialo-α-fetoprotein
in patients withα-fetoprotein producing tumors: Demonstration by affinity
electro- phoresis with erythroagglutinating phytohemagglutinin of Phaseolus
vulgaris lectin. Tumor Biol. 1985;6(6):533-544.
14) Mimura H, Hamana G, Ishitobi K, Momotani N, Ito K, Takami H. Graves'
disease complicating pregnancy results of surgical treatment in 35 pregnancies.
In: Vichayanrat A, Nitiyanant W, Eastman C, Nagataki S (eds), Recent progress
in thyroidology. Bangkok, Crystal House Press, pp 483-486, 1987
15) Nakamura K, Kubo A, Hashimoto S, Furuuchi T, Takami H, Abe O. Radioimmunodetection
of human pancreatic tumor xenografts using DU-PAN monoclonal antibody.
Ann Nuclear Med. 1988;2(1):1-6.
16) Takami H, Bessho T, Kameya T, Mimura T, Ito K, Abe O, Hosoda Y, Shikata
J. Immunohistochemical study of medullary thyroid carcinoma: Relationship
of clinical features to prognostic factors in 36 patients. World J Surg.
1988;12(4):572-579.
17) Ryusaki M, Konishi K, Kasuga A, Kumagai H, Suzuki H, Abe S, Saruta
T, Takami H, Tashiro M. Spontaneous rupture of the quadriceps tendon in
patients on maintenance hemodialysis-report of three cases with clinico-
pathological observations. Clin Nephrol. 1989;32(3):144-148.
18) Kakudo K, Takami H, Katayama S, Matsuura N, Kamoshida S, Miyauchi
A, Watanabe K. Carcinoembryonic antigen and nonspecific cross-reacting
antigen in medullary carcinoma of the thyroid. Acta Pathol Japonica. 1990;40(4):261-266.
19) Takami H, Shikata J. Serum bone Gla proteins as an indicator of parathyroidectomy
in patients with secondary hyperparathyroidism. World J Surg. 1990;14(3):431-436.
20) Takami H, Shikata J, Horie H, Sekine K, Ito K. PDN-21: Possible tumor
marker for medullary thyroid carcinoma. J Surg Oncol. 1990;44(4):205-207.
21) Takami H, Shikata J, Kakudo K, Ito K. Calcitonin gene-related peptide
in patients with endocrine tumors. J Surg Oncol. 1990;43(1):28-32.
22) Takami H, Shikata J. Graves' disease with severe iodine allergy:
Successful surgery after lithium carbonate treatment. Eur J Surg. 1991;157(8):489-490.
23) Takami H, Ito K. Calcitonin gene-related peptide as a tumor marker
for medullary thyroid carcinoma. Int Surg. 1992;77(3):181-185.
24) Miyaji S, Katakura K, Matsufuji S, Murakami Y, Hayashi S, Takami
H, Oku Y, Okamoto M, Kamiya M. Polyamine metabolism in Taeniid Metacestodes.
Jpn J Parasitol. 1992;41(4):327-333.
25) Takami H, Kodaira S. A rapid immunoperoxidase method for pathological
of occult thyroid carcinoma. Int Surg. 1993;78(3):225-228.
26) Takami H, Koudaira H, Kodaira S. Relationship of ornithine decarboxylase
activity and human colon tumorigenesis. Jpn J Clin Oncol. 1994;24(3):141-143.
27) Takami H, Kodaira S. Lithium in the surgical treatment of Graves'
disease. Int Surg. 1994;79(1):89-90.
28) Takami H. Measurement of serum PDN-21 levels by radioimmunoassay in
patients with various thyroid disease. Exp Clin Endocrinol. 1994;102(5):370-373.
29) Takami H, Kozakai M. Tuberculous thyroiditis: Report of a case with
a review of the literature. Endocr J. 1994;41(6):743-747.
30) Takami H. Clear cell carcinoma of the thyroid. Asian J Surg. 1995;18(3):241-243.
31) Taniguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T, Oishi S,
Takami H, Hikiji K, Nakamura Y. Germline mutation of the RET proto-oncogene
in eight Japanese patients with multiple endocrine neoplasia type 2A(MEN2A).
Hum Genet. 1995;95:187-190.
32) Takami H, Takada T. Clinical utility of tumor markers in hepatocellular
and pancreatic carcinomas. J Hep Bil Pancr Surg. 1995;2:395-400.
33) Takami H, Kodaira S, Osamura Y. An immunohitochemical and flowcytometric
study of gastroenterointestinal carcinoid tumors. J Exp Clin Cancer Res.
1995;14(4):401-407.
34) Takami H, Ozaki O, Ito K. Familial nonmedullary thyroid cancer: An
emerging entity that warrants aggressive treatment (Correspondence). Arch.Surg.
1996;131(6):676.
35) Takami H, Kodaira S. Spermidine/spermine N1-acetyltransferase as
a marker of dimethylhydrazine-induced colonic carcinogenesis in the rat.
Oncol Rep. 1996;3(3):575-577.
36) Takami H, Satake S, Nakamura K, Kubo,A. Technetium 99m sestamibi
is the useful procedure to locate parathyroid adenomas before surgery.
Am J Surg. 1996;172(1):93.
37) Takami H, Thosen T. Familial medullary thyroid carcinoma unassociated
with multiple endocrine neoplasia. Thyroidol Clin Exp. 1996;8:9-14.
38) Takami H. Current diagnosis and treatment of medullary thyroid carcinoma.
Thyroidol Clin Exp. 1996;8:35-39.
39) Takami H, Hosoda Y. Current status of multiple endocrine neoplasia
in Japan. Oncol Rep. 1996;3:943-946.
40) Takami H, Satake S, Nakamura K, Kubo A. What are the indications
for 99mTc-sestamibi scintigraphy in hyperparathyroidism? Clin Endocrinol.
1996;45:121-122.
41) Sugawara I, Satake S, Watanabe M, Nakamura K, Takami H, Kubo A, Akiyama
S, Itoyama S. Tumor imaging of multidrug-resistant cancers with organotechnetium
complex. Tumor Targeting. 1996;2:224-229.
42) Takami H, Miyoshi H, Makuuchi H. Relationship between thyroid diseases
and gastric lesions. Thyroidol Clin Exp. 1996;8:41-43.
43) Makuuchi H, Takami H, Hamana G, Kameyama K, Nishi,T. Duodenal carcinoid
tumor resected by strip biopsy. Oncol Rep. 1997;4:385-386.
44) Kitamura Y, Goodfellow PJ, Shimizu K, Nagahama M, Ito K, Kitagawa
W, Akasu H, Takami H, Tanaka S, Wells SA Jr. Novel germline RET proto-oncogene
mutations associated with medullary thyroid carcinoma (MTC): Mutation
analysis in Japanese patients with MTC. Oncogene. 1997;14:3103-3106.
45) Takami H. Surgical management of hyperparathyroidism in view of a
reliable parathyroid adenoma localization test. Surgery. 1997;122:120.
46) Satake S, Sugawara I, Watanabe M, Takami H. Lack of a point mutation
of human DNA topoisomerase Ⅱin multidrug-resistant anaplastic thyroid
cell lines. Cancer Lett. 1997;116:33-39.
47) Takami H, Sekine M, Miyoshi H, Kodaira S, Ohgami M. Laparoscopic
adrenalectomy in asymptomatic pheochromocytoma. Am Surgeon. 1997;63(9):820-822.
48) Takada T, Takami H. Solitary splenic metastsis of a carcinoid tumor
of the lung eight years postoperatively. J Srug Oncol. 1997;67(1):47-48.
49) Sekine M, Takami H. Combination of calcitonin and pamidronate for
emergency treatment of malignant hypercalcemia. Oncol Rep. 1997;5:197-199.
50) Sekine M, Takami H, Satake S, Kodaira S, Sugiyama F. Treatment of
skeletal and pulmonary metastases of differentiated thyroid carcinoma.
Thyroidol Clin Exp. 1997;9(3):89-94.
51) Shan L, Kakudo K, Nakamura M, Nakamura Y, Yokoi T, Ishimoto J, Kawahara
K, Takami H. Clonality of the parathyroid nodules with uremic parathyroid
hyperplasia. Pathol Oncol Res. 1997;3(3):198-203.
52) Kubo A, Nakamura K, Kawaguchi O, Satake S, Takami H. Successful Tc-99m
MIBI imaging of recurrent hyperparathyroidism in parathyroid autotransplanted
patients. Clin Nucl Med. 1997;22(12):872-874.
53) Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura
Y. Mutational analysis of the RET proto-oncogene in 71 Japanese patients
with medullary thyroid carcinoma. J Hum Genet. 1998;43(2):101-106.
54) Takami H, Ogino Y, Tanaka K, Kubo A. Somatostatin-receptor-negative
carcinoid tumor responsible for Cushing’s syndrome. Eur J Surg Oncol.
1998;24:337-338.
55) Takami H, Hayashi M, Konishi K, Maruyama H, Saruta T. Efficacy of
combined use of calcitonin and bisphosphonate for the treatment of hypercalcemia.
Intern Med. 1998;6(3):155-158.
56) Takami H. RET proto-oncogene mutation analysis for multiple endocrine
neoplasia type 2. Arch Surg. 1998;133(6):679.
57) Takami H, Miyoshi H, Makuuchi H. Strip biopsy for gastrointestinal
carcinoid tumor. J Surg Oncol. 1998;68:60-61.
58) Takami H, Thosen T, Shirahama S, Ogura K, Hikiji K. Does the syndrome
of familial medullary thyroid carcinoma describe a distinct clinical entity?
Eur J Cancer. 1998;34(10):1639-1640.
59) Takami HE. Management of medullary thyroid carcinoma (Mini review).
Thyroidol Clin Exp. 1998;10(2):59-65.
60) Takami H, Kameyama K, Nagakubo I. Parathyroid carcinoma in a chronic
hemodialysis patient. Surgery. 1999;125(2):239-240.
61) Takami H. Nationwide survey and analysis of the RET proto-oncogene
in inherited medullary thyroid carcinoma in Japan. In: Utsunomiya J, Mulvihill
JJ, Weber W (eds), Familial Cancer and Prevention. New York, Wiley-Liss,
pp 371-375, 1999
62) Takami H, Niimi M, Ikeda Y. Prognosis of a family with familial medullary
thyroid carcinoma. J Exp Clin Cancer Res. 1999;18(2):223-224.
63) Takami H, Ikeda Y, Niimi M. Ultrasonically activated scalpel for
subtotal thyroidectomy in Graves’ disease. Am J Surg. 1999;178(5):433-444.
64) Kameyama K, Takami H. Pigmented granules in functional black adenoma
of the adrenal gland a histochemical and ultrastructural study. Endocr
Pathol. 1999;10(4):353-357.
65) Takami H , Ikeda Y, Hayashi K, Hayashi M, Konishi K, Saruta T, Carpi
A. Clinical assessment of collagen cross-linked N-telopeptides as a marker
of bone metabolism in patients with primary hyperparathyroidism. Biomed
Pharmacother. 1999;53(7):329-333.
66) Kameyama K, Takami H. DNA cytofluorometric analysis using HP/DAPI
double staining of parathyroid carcinoma arising in a patient with chronic
renal failure and secondary hyperparathyroidism. Oncol Rep. 1999;6:1345-1347.
67) Takami H, Oshima M, Sugawara I, Satake S, Ikeda Y, Nakamura K. Kubo
A. Pre-operative localization and tissue uptake study in parathyroid imaging
with technetium-99m-sestamibi. ANZ J Surg. 1999;69:629-631.
68) Kameyama K, Takami H. Schwannoma of the neck mimicking a thyroid
tumor: a case report. Asian J Surg. 2000;23(2):175-176.
69) Niimi M, Shirasugi N, Hamano K, Esato K, Matsumoto K, Ikeda Y, Shatari
T, Takami H, Kodaira S. Oral delivery of xenoantigen combined with non-depleting
anti-CD4 monoclonal antibody induced significant prolonged survival of
concordant skin xenografts. Transplant Proc. 2000;32(5):1035.
70) Takami H, Ikeda Y, Wada N. Surgical management of primary hyperparathyrodism.
Biomed Pharmacother. 2000;54(Suppl 1):17-20.
71) Niimi M, Takashina M, Ikeda Y, Shirasugi N, Shatari T, Takami H,
Kodaira S, Kameyama K, Matsumoto K, Hamano K, Esato K. Mice treated with
Anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but
reject second-donor-type thyroid grafts in maintenance phase. Transplant
Proc. 2000;32(7):2086.
72) Takami H, Shirahama S, Ikeda Y, Sasaki Y, Wada N, Nimi M, Kameyama
K. Familial hyperparathyrodism. Biomed Pharmacother. 2000;54(Suppl 1):21-24.
73) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto
K, Hamano K, Esato K, Wood KJ. The thymus is essential for the development
of operational tolerance induced by donor-specific transfusion plus anti-CD4
monoclonal antibody. Transplant Proc. 2000;32(7):2067.
74) Kameyama K, Takami H, Sanders D, Giordano TJ. Surgical pathology
of hyperparathyroidism. Biomed & Pharmacother. 2000;54(Suppl 1):42-45.
75) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto
K, Hamano K, Esato K, Wood KJ. Intrathymic inoculation of donor B cells
induced indefinite prolongation of fully allogeneic cardiac grafts but
not islet or skin grafts. Transplant Proc. 2000;32:2020.
76) Ikeda Y, Takami H. Endoscopic parathyroidectomy. Biomed Pharmacother.
2000;54 (Suppl 1):52-56.
77) Nimi M, Takashina M, Takami H, Shirasugi N, Hamano K, Esato K, Matsumoto
K, Ikeda Y, Shatari T, Kodaira S. Kameyama K. Experimental parathyroid
transplantation: human parathyroid grafts survived and functioned in mice
treated with anti-CD4 monoclonal antibody. Biomed Pharmacother. 2000;54(Suppl
1):80-82.
78) Hanatani Y, Kobayashi H, Kodaira S, Takami H, Asagoe T, Kaneshiro
E. An in vitro chemosensitivity test for gastric cancer using collagen
gel droplet embedded culture. Oncol Rep. 2000;7(5):1027-1033.
79) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto
K, Hamano K, Esato K, Hara M, Wood KJ. Oral delivery of alloantigen combined
with non-depleting anti-CD4 monoclonal antibody induces indefinite survival
of cardiac allografts and generates CD4(+) regulatory T cells. Transplant
Proc. 2000;32(7):2035.
80) Kameyama K, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, Mimura
T, Ito K. PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas.
Ann Surg Oncol. 2000;7(4):301-305.
81) Ikeda Y, Takami H, Sasaki Y, Kan S, Niimi M. Endoscopic neck surgery
by the axillary approach. J Am Coll Surg. 2000;191(3):336-340.
82) Niimi M, Takashina M, Shirasugi N, Hamano K, Esato K, Matsumoto K,
Ikeda Y, Takami H, Kodaira S, Kameyama K. Human parathyroid grafts survived
and functioned in mice treated with anti-CD4 monoclonal antibody. Transplant
Proc. 2000;32(5):1040.
83) Ikeda Y, Takami H, Sasaki Y, Kan S, Niimi M. Endoscopic resection
of thyroid tumors by the axillary approach. J Cardiovasc Surg. 2000;41(5):791-792.
84) Niimi M, Ikeda Y, Shirasugi N, Shatari T, Takami H, Kodaira S, Matsumoto
K, Hamano K, Esato K, Hara M, Wood KJ. Oral administration of alloantigen
plus nondepleting anti-CD4 monoclonal antibody induces indefinite prolongation
of fully allogeneic cardiac allografts. Transplant Proc. 2000;32(2):259.
85) Miyaki M, Iijima T, Ishi R, Hishima T, Mori T, Yoshinaga K, Takami
H, Kuroi T, Iwama T. Molecular Evidence for Multicentric Development of
Thyroid Carcinomas in Patients with Familial Adenomatous Polyposis. Am
J Pathol. 2000;157(6):1825-1827
86) Niimi M, Takashina M, Takami H, Ikeda Y, Shatari T, Hamano K, Esato
K, Matsumoto K, Kameyama K, Kodaira S, Wood KJ. Overexpression of heme
oxygenase-1 protects allogeneic thyroid grafts from rejection in naive
mice. Surgery. 2000;128:910-917.
87) Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PHG, Treseler
PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH. Is
familial non-medullary thyriud carcinoma more aggressive than sporadic
thyroid cancer? A multicenter series. Surgery. 2000;128(6):1043-1051.
88) Shirasugi N, Matsumoto S, Hamano K, Esato K, Matsumoto K, Bashuda
H, Yagita H, Okumura K, Ikeda Y, Takami H, Kodaira S, Niimi M. Survival
of fully allogeneic cardiac allografts induced by delivery of alloantigen
via respiratory mucosa is abrogated by blockade of the B7 pathway. Transplant
Proc. 2000;32(7):2034.
89) Ikeda Y, Niimi M, Sasaki Y, Shatari T, Takami H, Kodaira S. Thoracoscopic
repair of a spontaneous perforation of the esophagus with the endoscopic
suturing device. J Thorac Cardiovasc Surg. 2001;121(1):178-179.
90) Takami H, Ikeda Y, Takayama J, Sasaki Y, Kan S, Niimi M, Inada E,
Kameyama K. Adrenal-sparing adrenalectomy in hereditary bilateral pheochromocytoma.
ANZ J Surg. 2001;71(10):623-624.
91) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Laparoscopic
partial or cortical-sparing adrenalectomy by dividing the adrenal central
vein. Surg Endosc. 2001;15(7):747-750.
92) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic
thyroidectomy and parathyroidectomy by the axillary approach: a preliminary
report. Surg Endosc 2001;16(1):92-95.
93) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic
total parathyroidectomy by the anterior chest approach for renal hyperparathyroidism.
Surg Endosc. 2001;16(2):320-322.
94) Shirasugi N, Ikeda Y, Akiyama Y, Matsumoto K, Hamano K, Esato K,
Bashuda H, Yagita H, Okumura K, Takami H, Kodaitra S, Niimi M. Induction
of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal
delivery of alloantigen. Transplantation. 2001;71(4):561-564.
95) Niimi M, Shirasugi N, Ikeda Y, Kan S, Takami H, Hamano K. Importance
of thymus to maintain operational tolerance to fully allogeneic cardiac
grafts. Ann Thorac Surg. 2001;72(3):735-739.
96) Ikeda Y, Niimi M, Kan S, Sasaki Y, Shatari T, Takami H, Kodaira S.
Mediastinoscopic esophagectomy using carbon dioxide insufflation via the
neck approach. Surgery. 2001;129(4):504-506.
97) Kameyama K, Takami H, Miyajima K, Miura T, Hosoda Y, Ito K, Ito K.
Papillary carcinoma occurring within an adenomatous goiter of thyroid
gland in Cowden’s disease. Endocr Pathol. 2001;12(1):73-86.
98) Niimi M, Shirasugi N, Ikeda Y, Kan S, Takami H, Hamano K. Operational
tolerance induced by pretreatment with donor dendritic cells under blockade
of CD40 pathway1. Transplantation. 2001;72(9):1556-1562.
99) Niimi M, Takashina M, Shirasugi N, Hamano K, Esato K, Matsumoto K,
Ikeda Y, Takami H, Kameyama K. Oral delivery of xeno-antigen combined
with non-depleting Anti-CD4 monoclonal antibody induces significantly
prolonged survival of concordant skin xenograft. Xenotransplantation.
2001;8(1):75-79.
100) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic
thyroidectomy by the axillary approach. Surg Endosc, 2001;15(11):1362-1364.
101) Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Clinical
significance of tissue blood flow during esophagectomy by laser Dopplerflowmetry.
J Thorac Cardiovasc Surg. 2001;122(6):1101-1106.
102) Shirasugi N, Akiyama Y, Ikeda Y, Kan S, Hamano K, Takami H, Kodaira
S, Niimi M. Intratracheal delivery of alloantigen induces donor-specific
hyporesponsiveness: dendritic cells play a pivotal role as regulatory
cells. Transplant Proc. 2001;33(1-2):86.
103) Shirasugi N, Ikeda Y, Akiyama Y, Matsumoto K, Hamano K, Esato K,
Bashuda H, Yagita H, Okumura K, Takami H, Kodaitra S, Niimi M. Induction
of hyporesponsiveness to fully allogeneic garafts by intratracheal delivery
of alloantigen. Transplantation. 2001;71(4):561-564.
104) Shirasugi N, Akiyama Y, Ikeda Y, Kan S, Hamano K, Takami H, Kodaira
S, Niimi M. Intratracheal delivery of alloantigen induces donor-specific
hyporesponsiveness: dendritic cells play a pivotal role as regulatory
cells. Transplant Proc. 2001;33(1-2):86.
105) Takami H, Ikeda Y. Endoscopic thyroidectomy via an axillary and
anterior chest approach. In: Gagner M, Inabnet WB (eds), Minimally Invasive
Endocrine Surgery, 1st ed. Philadelphia, Lippincott Williams & Wilkens
Publishers, pp 55-63, 2002
106) Takami H, Ikeda Y, Kan S, Kameyama K. New operative strategies in
primary hyperparathyroidism. Asian J Surg. 2002;25(2):184-187.
107) Ikeda Y, Niimi M, Kan S, Takami H, Kodaira S. Thoracoscopic Esophagectomy
Combined with Mediastinoscopy via the Neck. Ann Thorac Surg. 2002;73(4):1329-1331.
108) Kameyama K, Takami H. FAP associated thyroid carcinoma in mother
and her daughter. Familial Cancer. 2001;1:83-86.
109) Niimi M, Ikeda Y, Kan S, Takami H. Gas Gangrene in patient with
atherosclerosis obliterans. Asian Cardiovasc Thorac Ann. 2002;10(2):178-180.
110) Ikeda Y, Takami H, Sasaki Y, Takayama J, Kan S, Niimi M. Minimally
invasive video-assisted thyroidectomy and lymphadenectomy for micropapillary
carcinoma of the thyroid. J Surg Oncol. 2002;80:218-221.
111) Takami H, Ikeda Y. Minimally invasive thyroidectomy. ANZ J Surg.
72:841-842.
112) Ikeda Y, Sasaki Y, Niimi M, Kan S, Takami H, kodaira S. Hand-assisted
laparoscopic proximal gastrectomy with jejunal interposition and lymphadenectomy.
J Am Coll Surg. 2002;195(4):578-581.
113) Ikeda Y, Takami H, Sasaki Y, Takayama J, Kan S, Niimi M. Minimally
invasive video-assisted thyroidectomy and lymphadenectomy for micropapillary
carcinoma of the thyroid. J Surg Oncol. 2002;80:218-221.
114) Takami HE, Kameyama K, Sano T, Kakudo K, Sasano H, Osamura R. Y.
JEPS: Preface. Endocr Pathol. 2002;13:123.
115) Sano T, Kovacs K, Asa SL, Yamada S, Sanno N, Yokoyama S, Takami
H. Pituitary adenoma with “Honeycomb golgi” appearance showing a phenotypic
change at recurrence from clinically nonfunctioning to typical Cushing
disease. Endocr Pathol. 2002;13(2):125-130.
116) Kakudo K, Katoh R, Sakamoto A, Asa S,. DeLellis RA, Carney JA, Naganuma
H, Kameyama K, Takami H. Thyroid gland: International case conference.
Endocr Pathol. 2002;13(2):131-134.
117) Kameyama K, DeLellis RA, Recardo V, Kakudo K, Takami HE. Parathyroid
carcinomas: Can clinical outcomes parathyroid carcinomas be determined
by histologic evaluation alone? Endocr Pathol. 2002;13(2):135-139.
118) Sasano H, Suzuki T, Irie J, Kawai K, Aiba M, McNicol M, Takami H.
Adrenal cortical diseases: International case conference. Endocr Pathol.
2002;13:141-148.
119) Kumaki N, Kajiwara H, Kameyama K, Delellis RA, Asa SL, Osamura RY,
Takami H. Prediction of malignant behavior of pheochromocytomas and paragangliomas
using immunohistochemical techniques. Endocr Pathol. 2002;13:149-156.
120) Takami HE. Minimally invasive endocrine surgery: Preface. Biomed
Pharmacother. 2002;56: 3s.
121) Takami H. Parathyroid: Introduction. Biomed Pharmacother. 2002;56:5s-6s.
122) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi
M. Direct mini-incision parathyroidectomy. Biomed Pharmacother 2002;56:14s-17s.
123) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi
M. Total endoscopic parathyroidectomy. Biomed Pharmacother. 2002;56:22s-25s.
124) Takami H, Sasaki Y, Ikeda Y, Tajima G. Intraoperative quick parathyroid
hormone assay in the surgical management of hyperparathyroidism. Biomed
Pharmacother. 2002;56:26s-30s.
125) Takami H, Takayama J, Ikeda Y, Tajima G. Minimally invasive radioguided
parathyroidectomy. Biomed Pharmacother. 2002;56:37s-40s.
126) Takami H. Thyroid: Introduction. Biomed Pharmacother. 2002;56:53s-54s.
127) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi
M. Direct mini-incision thyroidectomy. Biomed Pharmacother. 2002;56:60s-63s.
128) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi
M. Total endoscopic thyroidectomy: axillary or anterior chest approach.
Biomed Pharmacother. 2002;56:72s-78s.
129) Takami H, Sasaki K, Ikeda Y, Tajima G, Kameyama K. Sentinel lymph
node biopsy in patients with thyroid carcinoma. Biomed Pharmacother. 2002;56:83s-87s.
130) Ikeda Y, Takami H. Adrenal overview. Biomed Pharmacother. 2002;56:104s-106s.
131) Ikeda Y, Takami H, Tajima G, Sasaki Y, Takayama J, Kurihara H, Niimi
M. Laparoscopic partial adrenalectomy. Biomed Pharmacother. 2002;56:126s-131s.
132) Otani Y, Furukawa T, Suganuma K, Yoshida M, Saikawa Y, Kubota T,
Kumai K, Mukai M,
Kameyama K, Takami H, Kitajima M. Minimally in invasive surgery for gastric
carcinoid
tumor. Biomed Pharmacother. 2002;56:217s-221s.
133) Ikeda Y, Takami H, Niimi M, Kan S. Sasaki Y. Takayama J. Endscopic
total parathyroidectomy by the anterior chest approach for renal hyperparathyroidism.
Surg Endosc. 2002;16:320-322.
134) Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y. Takayama J. Endoscopic
thyroidectomy and parathyroidectomy be the axillary approach. Surg Endosc.
2002;16:92-95.
135) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M, Kan S. Comparative
study of thyroidectomies. Endoscopic surgery versus conventional open
surgery. Surg Endosc. 2002;16(12):1741-1745.
136) Niimi M, Ikeda Y, Kan S, Takami H. Superficialization of hemodialysis
access using a video-assisted procedure. Surg Endosc. 2002;16(1):218.
137) Niimi M, Ikeda Y, Kan S, Takami H, Furui S, Takeshita K. Spontaneous
rupture of an intercostal artery due to neurofibromatosis type I disease
treated by percutaneous embolization. Cardiovasc Intervent Radiol. 2002;25(2):160-161.
138) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M. Kan S. Clinical
benefits in endoscopic thyroidectomy by the axillary approach. J Am Coll
Surg. 2003;196:189-195.
139) Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K,
Takami H, Takanami Y. Lymph node metastasis from 259 papillary thyroid
microcarcinoma: Frequency, pattern of occurrence and recurrence, and optimal
strategy for neck dissection. Ann Surg. 2003;237(3):399-407.
140) Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Conformal
radiation therapy for liver metastasis of esophageal carcinoma. Hepatogastroenterology.
2003;50:532-534.
141) Takami H. Ikeda Y. Total endoscopic thyroidectomy. Asian J Surg.
2003;26:82-85.
142) Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M, Kan S. Is laparoscopic
partial or cortical-sparing adrenalectomy worthwhile? Eur Surg. 2003;35(2):89-92.
143) Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S,
Kinouchi Y, Kameyama K, Takami H, Shimosegawa T, Sasano H. Estrogen receptors
(alpha and beta) and 17betahydroxysteroid dehydrogenase type 1 and 2 in
thyroid disorders:Possible in Situ estrogen synthesis and action. Modern
pathlogy. 2003;16(5):437-444.
144) Takami H. Medullary thyroid carcinoma and multiple endocrine neoplasia
type 2. Endocr Pathol. 2003;14(2):123-132.
145) Ikeda Y, Tobari S, Niimi M, Kan S, Takami H, Kodaira S. Reliable
cervical anastomosis through the retrosternal route with stepwise gastric
tube. J Thorac Cardiovasc Surg. 2003;125(6):1306-1312.
146) Takami H, Sasaki K, Ikeda Y, Tajima G, Kameyama K. Detection of
sentinel lymph nodes in patients with papillary thyroid cancer. Asian
J Surg. 2003;26(3):145-148.
147) Ikeda Y, Niimi M, Takami H, Kodaira S. Successfully treated carcinoma
erysipeloides from gastric cancer. Ann Oncol. 2003;14(8):1328-1329.
148) Shirasugi N, AkiyamaY, Aramaki O, Shibutani S, Matsumoto K, Bashuda
H, Yagita H, Okumura K, Ikeda Y, Niimi M, Kan S, Shatari T, Takami H,
Kodaira S, Uchida N, Shimazu M, Kitajima M, Hamano K. Role of the CTLA4
pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
Transplantation. 2003;75(10):1636-1639.
149）Takami H, Ikeda Y, Okinaga W, Kameyama K:Review:Recent advances in
the management of primary hyperparathyroidism. Endocrine J. 2003;50(4):369-377.
150）Kameyama K, Takami H. Double parathyroid carcinoma. Endocr J. 2003;50(4):477-479.
|
